ABSTRACT Background: Differences between mothers who do and do not succeed in breastfeeding are likely to confound associations of lactation with later maternal adiposity. Objective: We compared adiposity and blood pressure (BP) in women randomly assigned to an intervention to promote prolonged and exclusive breastfeeding or usual care. Design: We performed a cluster-randomized trial at 31 hospitals in Belarus in 1996-1997. Results: Of 17,046 women enrolled at delivery, we assessed 11,867 women (69.6%) at 11.5 y postpartum. The prevalence of exclusive breastfeeding $3 mo was 44.5% in 6321 women in the intervention group and 7.1% in 5546 women in the control group. At 11.5 y postpartum, mean (6SD) body mass index (BMI; in kg/m 2 ) was 26.5 6 5.5, the percentage of body fat was 33.6% 6 8.3%, and systolic BP was 124.6 6 14.6 mm Hg. On intention-to-treat analysis (without imputation) with adjustment for clustering by hospital, mean outcomes were lower in intervention compared with control mothers for BMI (mean difference: 20.27; 95% CI: 20.91, 0.37), body fat (20.49%; 95% CI: 21.25%, 0.27%), and systolic BP (20.81 mm Hg; 95% CI: 23.33, 1.71 mm Hg), but effect sizes were small, CIs were wide, and results were attenuated further toward the null after adjustment for baseline characteristics. Results were similar in sensitivity analyses [ie, by using conventional observational analyses disregarding treatment assignment, instrumental variable analyses to estimate the causal effect of breastfeeding, and multiple imputation to account for missing outcome measures (n = 17,046)]. Conclusion: In women who initiated breastfeeding, an intervention to promote longer breastfeeding duration did not result in an important lowering of adiposity or BP. This trial was registered at clinicaltrials.gov as NCT01561612 and at Current Controlled Trials as ISRCTN37687716.
INTRODUCTION
The reset hypothesis suggests that lactation plays a central role in mobilizing fat stores that a mother accumulates during pregnancy (1) . Two small randomized trials showed that mothers who breastfed exclusively for 6 compared with 4 mo lost more weight by 6 mo pospartum (2, 3) . However, these trials were conducted in a developing country with a very low prevalence of obesity and, thus, may have limited generalizability to populations at risk of obesity. In observational studies, most of which were conducted in Western populations, a longer breastfeeding duration has been associated with lower maternal weight, central adiposity, and blood pressure (BP) 5 and reduced future risk of diabetes and cardiovascular disease (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) .
Perhaps the most important limitation of previous observational studies is that both obesity and breastfeeding are strongly socially patterned (14, 15) . Substantial differences between mothers who do and do not choose to breastfeed may confound results from observational studies. Thus, it is difficult to determine whether observational associations of breastfeeding duration with maternal adiposity and other health outcomes are causal or have alternative explanations.
The Promotion of Breastfeeding Intervention Trial (PROBIT) trial, which was the largest breastfeeding trial ever conducted, successfully randomized units of medical care (maternity hospitals and their affiliated outpatient clinics) to a breastfeedingpromotion intervention (experimental group) or usual care (control group). The PROBIT intervention resulted in large contrasts in breastfeeding duration and exclusivity between the 2 groups (16). In the current study, we examined maternal adiposity outcomes in more than 11,800 PROBIT mothers evaluated at 11.5 y postpartum. We hypothesized that mothers randomly assigned to receive the breastfeeding intervention would have lower weight, body fat, and BP than would women randomly assigned to usual care.
SUBJECTS AND METHODS

Study setting and population
In 1996-1997, in the Republic of Belarus, 34 maternity hospitals and one each of their affiliated outpatient polyclinics were randomly assigned to receive a breastfeeding-promotion intervention (experimental group) or to continue the prevailing practices at the time of random assignment (control group) (17) . The experimental intervention was based on the Baby Friendly Hospital Initiative developed by the WHO and UNICEF to promote and support breastfeeding, particularly in mothers who have chosen to initiate breastfeeding (17) .
Mothers were eligible if they initiated breastfeeding, had no contraindications to breastfeeding, and delivered a healthy singleton infant of $37 wk of gestation, $2500 g birth weight, and with a 5-min Apgar score $5. Less than 5% of women did not initiate breastfeeding, and only 1-2% of eligible women declined participation. The experimental intervention included 10 steps that maternity hospitals implemented to become certified as Baby Friendly (17) , as summarized in detail previously (16) . A total of 17,046 mothers and their surviving children were randomly assigned, and 97% of subjects completed the initial 12-mo follow-up. The random assignment produced groups with similar distributions of potentially confounding sociodemographic and clinical characteristics (16) .
Physicians (obstetricians and pediatricians) at participating study sites recorded sociodemographic and clinical information during the postpartum stay. At polyclinic visits at 1, 2, 3, 6, 9, and 12 mo, pediatricians completed a data form that contained detailed information about infant feeding. On the basis of WHO definitions (16, 17) , we considered mothers to be exclusively breastfeeding at each time point if they provided their infant with only breast milk but no solids, nonhuman milk, water, or other liquids (other than vitamins or medications). A routine audit indicated excellent agreement between polyclinic charts and study documents regarding breastfeeding duration and exclusivity (16) . At a study visit at 6.5 y postpartum, we asked mothers to report their own current heights and weights (18) , the number of children born since the birth of the PROBIT child, and the number of months they breastfed each subsequent child.
Outcome assessment at 11.5 y postpartum From January 2008 through December 2010, we conducted follow-up visits (19) . One study pediatrician collected all outcome measures at each of the 23 smaller polyclinics, and 2 pediatricians shared the workload at each of the 8 larger sites.
Pediatricians obtained all measurements by using standard techniques. To ensure high-quality, standardized measurements (20) , we held a 3-d training workshop for participating pediatricians, which included lectures and practical sessions. We provided the pediatricians with a manual of procedures and training DVD. All materials were translated into Russian and back-translated into English. We held refresher (retraining) workshops every 6 mo thereafter.
Pediatricians measured maternal standing height by using a research stadiometer (Medtechnika) and weight by using a Tanita TBF 300GS body fat analyzer (Tanita Corporation Inc). If a mother did not attend the in-person visit, the pediatrician attempted to obtain self-reported weight and height via telephone. We calculated BMI (in kg/m 2 ) and defined obesity as BMI $30.0 (21). The Tanita analyzer also measured bioelectrical impedance from leg to leg and provided estimates of the percentage of body fat, fat mass, and fat-free mass. We calculated the fat mass index (FMI; in kg/m 2 ) and fat-free mass index (FFMI; in kg/m 2 ). We applied a threshold of body fat $40% on the basis of correlations with obesity in US surveillance data (22) . Pediatricians obtained a single measurement of maternal systolic BP and diastolic BP on the right arm by using the OMRON 705IT oscillometric device and an appropriate sized cuff (ie, the bladder of the cuff encircled $80% of the upper arm but not .100%). All mothers were sitting quietly, with their feet flat on the floor. Pediatricians also asked mothers whether they ever had a diagnosis of hypertension, type 2 diabetes, or gestational diabetes. Because of small numbers of reported outcomes, we did not further study type 2 (0.3%) or gestational diabetes (0.1%). We defined hypertension as measured systolic BP $140 mmHg, diastolic BP $90 mmHg (23), or a maternal report of hypertension diagnosis or treatment. Because confirmed hypertension generally requires elevated BP measurements on $2 occasions, we secondarily evaluated diagnosed hypertension as a maternal report of hypertension diagnosis or treatment and disregarded the single research measure of BP.
Quality assurance
Once data-collection began, each pediatrician was observed by 1 of 5 trained Belarussian monitors, who repeated key measurements made during 1 d of study visits per pediatrician. The monitors did not identify any problems with maternal outcome measurements. Once the data collection was complete, we conducted remeasurement audit visits to assess interobserver reproducibility, which was an important step because pediatricians were not blinded to the randomization status. So that all mothers seen in follow-up were eligible for selection, repeated measurements were carried out on randomly selected mothers at each of the polyclinics after completion of the primary data collection, which was an average of 1.3 y (range: 0.2-2.2 y) after the initial study visit. Auditors were blinded to initial measurements (but not to the experimental or control status). Correlations for 143 repeat measures were excellent for height (Spearman's correlation coefficient = 0.99), weight (r = 0.93), and body fat (r = 0.83) and very good for systolic BP (r = 0.53) and diastolic (r = 0.57) BP.
Ethics
The PROBIT III study protocol was approved by Human Subjects Committees at Harvard Pilgrim Health Care, the Montreal Children's Hospital, and the Law and Ethics Committee at the University of Bristol. All procedures were conducted in accordance with ethical standards (24) . All mothers provided written informed consent in Russian at enrollment and outcome visits.
Statistics
For each of the measured outcomes, we calculated the intraclass correlation (ICC) (20) . The ICC is a statistic that can be used to quantify the degree to which observations within a cluster differ from those between clusters. An ICC close to 0 indicates a low degree of clustering (ie, most of the variation occurs within polyclinics), whereas an ICC close to 1 suggests a high degree of clustering (ie, most of the variation occurs between polyclinics). We calculated cluster-adjusted HRs for discontinuing any and exclusive breastfeeding with the SAS phreg procedure (SAS version 9.3; SAS Institute).
In a modified intention-to-treat analysis (ie, without imputation for missing outcome measures), we evaluated the effect of the breastfeeding intervention on maternal BMI, body composition, and systolic and diastolic BPs by using the MIXED procedure in the SAS program (SAS version 9.3; SAS Institute) and on maternal obesity, excess body fat, and hypertension by using the GLIMMIX procedure in the SAS program. We accounted for clustering by clinic in all analyses by adding a random effect (for study site). We carried out additional analyses in which we also adjusted for maternal baseline characteristics and for polyclinic location (urban compared with rural; East compared with West Belarus). We excluded from each analysis women missing the outcome measurement. Because it was possible that the effect of the experimental intervention may have waned by 11 y postpartum, we also examined associations with self-reported maternal BMI at 6.5 y postpartum.
In addition, we conducted sensitivity analyses as follows. We performed observational analyses (ie, on the basis of actual breastfeeding duration and exclusivity, disregarding randomized treatment allocation), in which we estimated the effects of the duration of any breastfeeding and exclusive breastfeeding (both continuous and in categories) on the same outcomes, accounting for clustering and baseline characteristics by using the same statistical procedures. We also conducted instrumental variable analyses to estimate the causal effect of the duration of any breastfeeding and exclusive breastfeeding by using the randomly assigned PROBIT intervention group as an instrument, akin to the use of instrumental variables to adjust for noncompliance in randomized controlled trials (25) . We performed instrumental variable estimation by using the generalized 2-stage least-squares estimator (26) implemented in the xtivreg command in Stata software (version 11.2; Stata Corp), while accounting for clustering by study site. We also examined associations of breastfeeding consistent with recommendations of the American Academy of Pediatrics (27) and the WHO (28) (ie, exclusive breastfeeding for 6 mo plus continued breastfeeding for $12 mo).
Not all of the mothers who were randomly assigned at birth attended the 11.5-y postpartum visit. In an additional sensitivity analysis, we investigated whether an incomplete follow-up influenced the results by undertaking multiple imputation to generate plausible values of missing 11.5-y maternal outcomes (29, 30) . In this analysis, we imputed data for all of the 17,046 mothers who were randomly assigned at birth. We used SAS imputations (Proc MI) to impute 5 values for each missing observation and combined multivariable modeling estimates by using Proc MI ANALYZE in the SAS program.
RESULTS
Of the 17,046 mothers and their infants originally randomly assigned, 13,882 children attended PROBIT III visits, of whom 3 children were unable to provide verifiable assent, which left 13,879 eligible children (19, 31) . We had information on one or more adiposity measures for 11,867 mothers (69.6%). The median follow-up time for mothers was 11.6 y (range: 10.3-13.9 y). We obtained BMI in 11,751 women (9491 women had measured weight, and the remainder was self-reported), body fat measures from 9392 mothers, and BP measures from 9383 mothers (Figure 1) . Baseline characteristics of included women were similar across the randomly assigned groups ( Table 1 ). Small differences in some categorical variables were attributable to the cluster-based random assignment and incomplete follow-up.
The intervention substantially increased the breastfeeding duration and exclusivity; eg, compared with mothers in the control arm, intervention mothers were 6 times more likely to be exclusively breastfeeding at 3 mo postpartum (44.5% compared with 7.1%, respectively) and were breastfeeding to any degree at higher rates throughout the postpartum period. Risk of discontinuing breastfeeding was substantially lower in intervention compared with control mothers [cluster-adjusted HR for any breastfeeding 0.67 (95% CI: 0.55, 0.81); and for exclusive breastfeeding, HR was 0.25 (95% CI: 0.18, 0.36)].
At 11.5 y postpartum, mean (6SD) maternal BMI was 26.5 6 5.5, FMI was 9.4 6 4.2, FFMI was 17.4 6 2.0, percentage of body fat was 33.6 6 8.3%, systolic BP was 124.6 6 14.6 mm Hg, and diastolic BP was 77.7 6 10.4 mm Hg; 22.5% of mothers were obese (BMI $30). There was a low degree of within-polyclinic clustering for all outcomes (all ICCs #0.05; Table 2 ). Measures of adiposity and BP were lower in women who had been randomly assigned to the intervention group (Table 2) . However, in an intention-to-treat analysis that accounted for clustering, we observed only weak evidence for any differences in intervention compared with control mothers for BMI ( Results were attenuated markedly toward the null when further adjusting for recruitment hospital/polyclinic location, maternal age and education, smoking, and the number of children in the household (Table 2) . Although mean BMI and obesity prevalence were higher in mothers with measured weight than in mothers who self-reported, differences between intervention and control mothers were similar when they were based on measured weight than when they were based on all data (self-reported and measured), and results of regression analyses of BMI outcomes were almost identical when we limited analyses to women with measured weight (Table 2) . Evidence of any interventioncompared with control-group effect was similarly weak for odds of obesity, high body fat, and any or diagnosed hypertension (Table 2) We performed observational analyses by examining the effects of each mother's achieved breastfeeding duration and exclusivity, regardless of her treatment allocation ( Table 3) . There was no evidence for an association of exclusive breastfeeding with lower maternal BMI, body fat, or systolic BP or of any breastfeeding with BMI or body fat (Table 3 ). There was some indication of lower BP with any breastfeeding, although the association was strongest in the group with any breastfeeding $6 to ,9 mo and less strong with longer durations (Table 3) . Results for weight and FMI were similar to those for the percentage of body fat, and results for diastolic BP were similar to those for systolic BP (data not shown). Exclusive breastfeeding for $6 mo followed by any breastfeeding for $12 mo, as recommended by the American Academy of Pediatrics and WHO, was paradoxically associated with somewhat higher maternal BMI (0.47; 95% CI: 20.31, 1.25) and percentage of body fat (1.30%; 95% CI: 0.01, 2.56%) ( Table 3) .
Intervention women reported a substantially longer lactation duration than that of control women not only for the children enrolled in PROBIT (Table 3) but also for subsequent children Table 1 under "Supplemental data" in the online issue].
Instrumental variable estimates by using the randomly assigned PROBIT intervention group as the instrument were in the same direction as observational estimates for both the duration of exclusive and any breastfeeding; however, all estimates had wide CIs including the null ( Table 4) . In an analysis that used multiply imputed data with modeling of outcomes for all 17,046 mothers randomly assigned at birth, estimated effects of the randomized intervention (see Supplemental Table 2 under "Supplemental data" in the online issue) and observational associations with breastfeeding (see Supplemental Table 3 under "Supplemental data" in the online issue) were virtually identical to analyses that were based on observed outcome data.
DISCUSSION
Contrary to the hypothesis, we did not show that women who initiated breastfeeding and were randomly assigned to a successful intervention to promote longer breastfeeding duration and exclusivity had significantly lower adiposity or BP at 11.5 y postpartum. A number of factors that predict postpartum weight and BP also strongly predict the initiation and duration of breastfeeding, including prepregnancy weight and gestational weight gain (32) . In our study, confounding was minimized by the stringent random-allocation procedure, which produced intervention and control groups with similar baseline characteristics (16) . We were also able to account for concurrently measured baseline characteristics in our analyses. Breastfeeding was assessed repeatedly during infancy, not recalled remotely, and exposure and outcome measures were shown to be valid and reproducible.
In agreement with our findings, a 2009 systematic review of observational studies concluded that the effect of lactation on return to prepregnancy weight was negligible, and many other factors had larger effects (33) . Methodologic challenges in reviewed studies included accurately measuring weight change, adequately controlling for numerous covariables (including weight entering pregnancy and weight gained during pregnancy), and precisely quantifying the exclusivity and duration of breastfeeding.
In large observational studies that have evaluated maternal outcomes over years or decades after the pregnancies or mothers, results have similarly been inconsistent. In 570 US women in the Project Viva longitudinal cohort study, a longer duration of lactation was not associated with lower weight retention, BMI, or blood cardiometabolic risk markers at 3 y postpartum (34) . In w4000 US women in the Nurses' Health Study II, lactation to any degree was associated with an w1-kg greater weight increase over the period 1989-1993 than in women who became pregnant but did not breastfeed (35) . In both study populations, women who breastfed for a longer duration were less likely to be overweight or to smoke before pregnancy. In .700,000 women with a mean age of 57 y who participated in the UK Million Women Study, BMI was 0.13 (95% CI: 20.11, 20.13) lower for every 6 mo lifetime lactation (13) , which was a small effect that was, nevertheless, excluded by our result in which the lower confidence limit of the estimate for 6 mo of cumulative breastfeeding was 20.06. Prepregnancy BMI was not assessed, although women who had breastfed for a longer duration were of a higher socioeconomic status. In the WHO Multicentre Growth Reference Study, which included 1743 women from Brazil, Ghana, India, Norway, Oman, and the United States, breastfeeding frequency did not vary by prepregnancy BMI, and the lactation duration and intensity explained little of the variation in maternal weight change to 24 mo postpartum (36) .
Lactation could theoretically influence body composition or metabolism without a direct effect on weight. Two studies showed that lactation $3 mo per child (compared with none) was associated with lower visceral adiposity, although no effect was observed on overall adiposity (4, 5) . In postpartum women with recent gestational diabetes, a higher intensity of lactation was associated with improved fasting glucose and lower insulin concentrations at 6-9 wk postpartum (12) . In PROBIT, we did not assess visceral adiposity or measure glucose tolerance, and the number of women who developed type 2 diabetes by 11.5 y postpartum was too small to permit analysis.
Physiologic changes associated with breastfeeding also may benefit maternal BP (37, 38) . Only a few long-term studies have examined these associations. In 4700 women enrolled in NHANES III (7), breastfeeding .1 compared with #1 mo was associated with a reduced odds of the metabolic syndrome (OR: 0.78; 95% CI: 0.61, 0.99), of which elevated BP is one component. In the Women's Health Initiative, women with a lifetime history of $12 mo lactation were less likely to have hypertension (OR: 0.88; P , 0.001) than were women who had never breastfed. In the Nurses' Health Study II, never or curtailed lactation was associated with increased risk of incident maternal hypertension compared with that for the recommended $6 mo exclusive or $12 mo total lactation per child (39) . In the Coronary Artery Risk Development in Young Adults study, mothers who had breastfed had lower systolic BP (101.6 compared with 105.3 mm Hg) and diastolic BP (64.9 compared with 66.4 mm Hg) that did mothers who had not breastfed, although differences did not persist after adjusted analyses (6) . A major limitation of the observational breastfeeding literature is that unmeasured or residual confounding may well explain the findings, because the exposures have been based on maternal choices about or success with breastfeeding. The Coronary Artery Risk Development in Young Adults study, which has followed a cohort of young women longitudinally, has the advantage of being able to account for differences in measured prepregnancy, as well as prenatal and postpartum, factors that may confound relations (6, 40) . However, inadequate control for factors that predict both breastfeeding success and later outcomes remains a plausible alternative explanation for observed associations.
Despite the large sample size, it is possible that our study was underpowered to detect a small but real difference in measured outcomes. Confidence limits were widened by accounting for the clustering of both the intervention (mothers were clustered within the polyclinic and, thus, would tend to have more-similar characteristics) and measurement (a tendency for measurements made by a polyclinic pediatrician to be more similar than measurements between clinics). (41) . However, intraclass correlation coefficients for all outcomes of interest were low. Furthermore, any true difference between groups was likely to have been small (eg, the OR for obesity was 0.96, and there was a 0.23-mm Hg lowering of systolic BP. It is possible that breastfeeding has a shorter-term effect on maternal adiposity and BP that is no longer present at 11.5 y postpartum, although we also saw no evidence for an effect on weight at 6.5 y postpartum.
Our breastfeeding-promotion intervention did not result in complete separation between groups; some women in the control group exclusively breastfed .3 mo, and many women in the intervention group discontinued exclusive breastfeeding. Therefore, even if longer lactation duration is associated with modest improvements in maternal adiposity, a breastfeeding-promotion intervention is not likely to substantially improve maternal obesity or BP on a population level. All women in the cohort initiated breastfeeding, and thus, our study could not evaluate outcomes in women who never breastfed.
We obtained a single measure of systolic and diastolic BP. Repeat measures may be more reflective of basal BP (23) . Leg-leg bioimpedance methods may underestimate body fat compared with other methods such as a 4-compartment model, although comparisons between different methods suggested that this method has reasonable validity and is able to accurately rank individuals and groups (42, 43) . Any measurement error in continuous outcome variables would have added to the residual variance and, therefore, decreased power. Although the polyclinic pediatricians could not be blinded to the intervention or control status, the primary measures (weight, bioimpedance, and BP) were assessed by using calibrated, automated equipment and, thus, should not have been operator dependent. Furthermore, maternal outcomes were not a primary study hypothesis, and the duplicate audit visits provided evidence of validity. Losses to follow-up and incomplete data were potential sources of bias, but
TABLE 2
Associations of experimental intervention with maternal adiposity and blood pressure at 11.5 y postpartum in 11,867 women in the PROBIT study Results are from multilevel logistic regression analyses.
4
Location of polyclinic, maternal age, maternal education, number of children in the household, and smoking during pregnancy.
the analysis that was based on multiple imputation provided some reassurance against such biases. We did not collect information on maternal prepregnancy BMI, gestational weight gain, or BP before or during pregnancy or on menopausal status at the outcome assessment, but the randomization procedure should have balanced these factors across intervention and control sites. Because the study was in Belarus, all participants were white. However, PROBIT includes an economically diverse population, and fewer than 2% of eligible mothers refused initial participation in PROBIT (16) . Belarus resembles developed Western countries in both basic health services and sanitary conditions, although obesity rates are lower than in many other settings.
In conclusion, by using data from a large, cluster-randomized controlled trial that minimized confounding, we did not see evidence that the longer breastfeeding duration and greater exclusivity achieved by the intervention led to an important lowering of maternal adiposity or BP. Breastfeeding has many advantages, but it is unlikely that interventions to promote a longer duration of exclusive breastfeeding will confer important long-term benefits for maternal adiposity or BP.
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